Healthcare provider profile · identity verified

Renu Yadav, MD

Internal Medicine · MALONE, NY · NPI 1669620985

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	334	96
Omeprazole	Omeprazole	223	63
Levothyroxine Sodium	Levothyroxine Sodium	209	59
Amlodipine Besylate	Amlodipine Besylate	201	62
Lisinopril	Lisinopril	189	65
Losartan Potassium	Losartan Potassium	167	43
Pantoprazole Sodium	Pantoprazole Sodium	167	48
Metoprolol Succinate	Metoprolol Succinate	161	51
Albuterol Sulfate Hfa	Albuterol Sulfate	159	42
Metformin Hcl	Metformin Hcl	129	40
Gabapentin	Gabapentin	124	35
Simvastatin	Simvastatin	104	27
Furosemide	Furosemide	99	41
Sertraline Hcl	Sertraline Hcl	95	23
Pravastatin Sodium	Pravastatin Sodium	92	27
Ozempic	Semaglutide	85	16
Rosuvastatin Calcium	Rosuvastatin Calcium	83	28
Tramadol Hcl	Tramadol Hcl	81	17
Allopurinol	Allopurinol	73	16
Potassium Chloride	Potassium Chloride	72	25
Fluticasone Propionate	Fluticasone Propionate	71	24
Jardiance	Empagliflozin	70	18
Escitalopram Oxalate	Escitalopram Oxalate	64	19
Metoprolol Tartrate	Metoprolol Tartrate	64	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	21
Metformin Hcl Er	Metformin Hcl	55	15
Eliquis	Apixaban	54	17
Duloxetine Hcl	Duloxetine Hcl	53	17
Atenolol	Atenolol	52	13
Clonazepam	Clonazepam	52	11
Glipizide	Glipizide	51	13
Hydrochlorothiazide	Hydrochlorothiazide	51	14
Januvia	Sitagliptin Phosphate	48	11
Trazodone Hcl	Trazodone Hcl	44	15
Zolpidem Tartrate	Zolpidem Tartrate	44	suppressed
Azithromycin	Azithromycin	43	29
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	suppressed
Finasteride	Finasteride	39	suppressed
Montelukast Sodium	Montelukast Sodium	39	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	11
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Warfarin Sodium	Warfarin Sodium	37	suppressed
Xarelto	Rivaroxaban	36	suppressed
Alprazolam	Alprazolam	35	11
Topiramate	Topiramate	32	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Famotidine	Famotidine	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Ramipril	Ramipril	30	11
Ibuprofen	Ibuprofen	29	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	28	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Nystatin	Nystatin	27	suppressed
Telmisartan	Telmisartan	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	11
Ondansetron Odt	Ondansetron	23	suppressed
Prednisone	Prednisone	23	17
Glipizide Er	Glipizide	22	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	14
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Prazosin Hcl	Prazosin Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Naproxen	Naproxen	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Carvedilol	Carvedilol	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Diazepam	Diazepam	15	suppressed
Linzess	Linaclotide	15	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Torsemide	Torsemide	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Megestrol Acetate	Megestrol Acetate	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Steglatro	Ertugliflozin Pidolate	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Glimepiride	Glimepiride	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error